Dr. Vasvi Singh Wins First ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award

ASNC congratulates Vasvi Singh, MD, recipient of the first ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award. Please join us at the ASNC2020 Virtual Scientific Session, where Dr. Singh will be presented with $50,000 to support her research proposal, “Screening for Early ATTR Cardiac Amyloidosis by 99mTc-PYP SPECT/CT in Older Adults With HFpEF and Sarcopenia.” 

Dr. Singh is the Amyloidosis Research Fellow in the Division of Nuclear Medicine and Molecular Imaging and the Department of Radiology at Brigham and Women's Hospital and Harvard Medical School in Boston. 

The ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award was established through a grant from Pfizer, Inc. The award is part of ASNC's broad effort to expand opportunities for clinical research in cardiac amyloidosis and improve the outcomes of patients with ATTR cardiac amyloidosis. The awardee is an early-career researcher whose proposal has the potential to advance both the science of cardiac imaging and the nuclear cardiology specialty. 

“We received excellent proposals in competition for this award, which underwent careful peer review by experts in the field,” says Albert Sinusas, MD, FASNC, chair of the ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award Selection Committee. “Dr. Singh's proposal was considered a truly outstanding and innovative project. The committee also felt that Dr Singh has a bright future in nuclear cardiology and anticipates that her work will have a significant impact in the area of cardiac amyloidosis.” 

Dr. Singh will be honored on Friday, Sept. 25, during the ASNC2020 Clinical Solutions session “Amyloid Best Practices,” which also will feature moderator Donna M. Polk, MD, MPH, FASNC; Frederick L. Ruberg, MD; Jamieson M. Bourque, MD, FASNC; Omar F. Abouezzeddine, MDCM; and Sharmila Dorbala, MD, MPH, FASNC. To participate in this and more than 40 additional sessions, register for your ASNC2020 All-Access Pass now. 

Among many highlights, ASNC2020 will include a number of sessions addressing cardiac amyloidosis; for example –  
  • “Diversity and Inclusion in Clinical Nuclear Cardiology: A Case-based Ethics Session”;
  • “Imaging Innovations to Improve Outcomes”; and
  • "Technology & Techniques: Cardiac Amyloidosis (PYP) Imaging.

As an ASNC2020 All-Access Passholder, you will enjoy 20+ live virtual sessions on Sept. 25-26; unlimited access to Meeting OnDemand (MOD) for 12 months; and up to 55+* CME, 29* ABIM MOC points, and 30* ARRT Category A Credits. 


*Credits subject to change. MOC and ARRT available for live sessions only. CME available for live and on-demand sessions.